Related Experiment Video
Updated: May 17, 2026

SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs
Published on: June 28, 2019
Metallothioneins, ageing and cellular senescence: a future therapeutic target
Eugenio Mocchegiani1, Laura Costarelli, Andrea Basso
1Trans. Res. Ctr. of Nutrition and Ageing, IRCCS-INRCA, Via Birarelli 8, 60121, Ancona, Italy. e.mocchegiani@inrca.it
Abstract:
In ageing, the accumulation of damaged molecules provoked by oxidative stress and inflammation contributes to altered gene expressions and cellular dysfunction. The antioxidant system is crucial in order to prevent damage to intracellular molecules including DNA and, consequently, to avoid cellular dysfunction or neoplastic transformation. However, during serious DNA damage, the cells can activate a response characterized by cell cycle arrest and production of factors (mainly chemokines and cytokines) named "senescent associated secretory phenotype" (SASP) with the putative function to attract immune cells involved in the clearance of the senescent cells. This phenomenon named "cellular senescence" is, by one side, an important tumor suppressive mechanism but, on the other side, it contributes to impair tissue regenerative capacity and to possible transformation of neighbouring cells to cancer cells if a rapid clearance of the senescent cell doesn't occur. Therefore, preventing DNA damage via an optimal intracellular antioxidant defence is the key to reduce risk of cancer while keeping senescent changes at minimum. Zinc-bound Metallothioneins (MT), could play a key role in this prevention because they are antioxidant proteins and release zinc ions for several proteins and enzymes involved in antioxidant and DNA-repair responses. Reduced MT expression and intracellular zinc occur in some models of senescent cells. This process is of relevance since zinc ions released from MT could be implicated in the modulation of SASP. In chronic inflammation, such as in ageing, the dysfunction in zinc release from MT occurs, suggesting a potential contribution to the onset of senescent cells. Hence, MT could be directly or indirectly involved in the modulation of cellular senescent state and might represent a possible therapeutic target against the accumulation of dysfunctional senescent cells.
Insights
Metallothioneins (MT) protect against DNA damage and cellular senescence by releasing zinc ions. Dysfunction in this process contributes to aging and cancer, highlighting MT as a therapeutic target.
Area of Science:
- Cellular biology
- Molecular biology
- Aging research
Background:
- Oxidative stress and inflammation in aging cause molecular damage, leading to altered gene expression and cellular dysfunction.
- The antioxidant system, including DNA repair mechanisms, is vital for preventing cellular damage and neoplastic transformation.
- Cellular senescence, a response to DNA damage, involves cell cycle arrest and the release of factors (senescence-associated secretory phenotype - SASP) that can impair tissue regeneration and promote cancer if clearance is delayed.
Purpose of the Study:
- To investigate the role of zinc-bound Metallothioneins (MT) in preventing DNA damage and modulating cellular senescence.
- To explore the connection between MT dysfunction, zinc ion release, and the senescence-associated secretory phenotype (SASP).
- To assess the potential of MT as a therapeutic target for managing dysfunctional senescent cells.
Main Methods:
- The study focuses on the known functions of MT as antioxidant proteins and zinc ion donors.
- It examines the observed reduction in MT expression and intracellular zinc in senescent cells.
- The research considers the implications of zinc ion release from MT in modulating SASP and cellular senescence.
Main Results:
- Reduced MT expression and intracellular zinc levels are observed in senescent cells.
- Dysfunctional zinc release from MT, particularly in chronic inflammation and aging, may contribute to the onset of cellular senescence.
- Zinc ions released by MT appear to be involved in modulating the senescence-associated secretory phenotype (SASP).
Conclusions:
- Metallothioneins (MT) play a crucial role in cellular defense against DNA damage and senescence through their antioxidant properties and zinc ion release.
- Impaired MT function and zinc dysregulation are implicated in aging and the accumulation of senescent cells.
- MT represent a potential therapeutic target for mitigating the negative effects of dysfunctional senescent cells.
Related Concept Videos
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Mitochondria
Aging
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
The Effect of Aging on Tissues
Telomeres and Telomerase
Replicative Cell Senescence
